Rivista
/
Ricerca sul cancro
/
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
JoVE Journal
Ricerca sul cancro
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Ricerca sul cancro
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

DOI:
10.3791/59696-v

•

10:03 min

•

July 05, 2019

•

, , , , , , ,
1Department of Biomedical Engineering,University of Michigan, 2Department of Materials Science and Engineering,University of Michigan, 3Rogel Cancer Center, School of Medicine,University of Michigan, 4Macromolecular Science and Engineering,University of Michigan

Capitoli

  • 00:04Titolo
  • 01:26Generation of Spheroids from Small Cell Numbers
  • 02:44Quantification of Proliferation and Viability within Spheroids
  • 03:33Analysis of Cancer Stem Cell Populations with Flow Cytometry
  • 05:15FACS Data Analysis
  • 08:03Results: Patient-derived Cancer Stem Cells within 3D Hanging Drops
  • 09:03Conclusion

Summary

Traduzione automatica

Traduzione automatica

This protocol describes generation of patient-derived spheroids, and downstream analysis including quantification of proliferation, cytotoxicity testing, flow cytometry, immunofluorescence staining and confocal imaging, in order to assess drug candidates’ potential as anti-neoplastic therapeutics. This protocol supports precision medicine with identification of specific drugs for each patient and stage of disease.

Tags

3D Cell CultureSpheroidsHanging Drop ModelAnti-neoplastic Drug ScreeningCancer Stem CellsPatient-derived SamplesHeterogeneityChemo ResistanceOvarian CancerTargeted TherapiesPatient-specific TreatmentsHigh-throughput Screening

Article

Embed

AGGIUNGI ALLA PLAYLIST

Usage Statistics

Video correlati

check_url/it/59696?article_type=v

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
check_url/it/59696?article_type=v

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
check_url/it/59696?article_type=v

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
check_url/it/59696?article_type=v

Patient-Derived Tumor Explants As a “Live” Preclinical Platform for Predicting Drug Resistance in Patients
check_url/it/59696?article_type=v

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
check_url/it/59696?article_type=v

Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
check_url/it/59696?article_type=v

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
check_url/it/59696?article_type=v

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
check_url/it/59696?article_type=v

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
check_url/it/59696?article_type=v

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Read Article